Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC Study
Title: | Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC Study |
---|---|
Authors: | Boothman, Anne-Marie, Scott, Marietta, Ratcliffe, Marianne, Whiteley, Jessica, Dennis, Phillip A., Wadsworth, Catherine, Sharpe, Alan, Rizvi, Naiyer A., Garassino, Marina Chiara, Walker, Jill |
Source: | In Journal of Thoracic Oncology August 2019 14(8):1390-1399 |
Database: | ScienceDirect |
ISSN: | 15560864 |
---|---|
DOI: | 10.1016/j.jtho.2019.04.025 |
Published in: | Journal of Thoracic Oncology |
Language: | English |